Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
56 participants
INTERVENTIONAL
2024-09-23
2028-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Patient Outcomes 5 Years After Partial Knee Replacement
NCT01620892
Effectiveness of Minimally Invasive Total Knee Replacement in Improving Rehabilitation and Function
NCT00710840
Chronic Knee Pain Study
NCT00776932
A Global Clinical Study Investigating the Safety and Effectiveness of Smith and Nephew's Porous Knee System in Patients Who Need a Total Knee Replacement Due to Degenerative Arthritis, Post-traumatic Arthritis or Inflammatory Arthritis
NCT05197036
A Study of Orthotic Shoe Inserts for Controlling Osteoarthritic Knee Pain
NCT00076453
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interventional Group
Participants who meet study criteria and are enrolled in adaptive daily step promotion intervention
Adaptive Daily Step Promotion
Participants will wear a Fitbit monitor on their non-dominant wrist during a 10 to 14 day "run-in" screening to capture daily steps reported by the Fitbit but no daily step goals will be sent to the participant. The Fitbit monitor will be worn during all waking hours except water activities, and compliance will be considered as a day with ≥1,000 steps. Next, participants will undergo a 16-week intervention wearing the Fitbit monitor on their wrist and receive a text message each morning with a personalized, adaptive daily step count goal and a link used to confirm receipt of the goal. The preceding 10 days of step data will be rank ordered and the 60th percentile step count will be set as the goal for the next day. Goals will not exceed 10,000 daily steps.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adaptive Daily Step Promotion
Participants will wear a Fitbit monitor on their non-dominant wrist during a 10 to 14 day "run-in" screening to capture daily steps reported by the Fitbit but no daily step goals will be sent to the participant. The Fitbit monitor will be worn during all waking hours except water activities, and compliance will be considered as a day with ≥1,000 steps. Next, participants will undergo a 16-week intervention wearing the Fitbit monitor on their wrist and receive a text message each morning with a personalized, adaptive daily step count goal and a link used to confirm receipt of the goal. The preceding 10 days of step data will be rank ordered and the 60th percentile step count will be set as the goal for the next day. Goals will not exceed 10,000 daily steps.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For children, signed and dated informed assent by child and parental permission form by parent/guardian to participate in the study
* Underwent an anterior cruciate ligament reconstruction (ACLR) between 6-60 months prior to enrollment
* Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study
* Completed all other formal physical therapy and therapeutic exercise regimens, and will not be engaging in any other formal therapy for their ACLR during the study
* Physician clearance for unrestricted activity
* Owning a smartphone
* Demonstrate \< 7,000 steps per day during the screening phase of aim 2 as assessed using the Actigraph Link monitor
Exclusion Criteria
* A multiple ligament surgery was indicated with their ACL injury
* A lower extremity fracture was suffered during the ACL injury
* The participant has previously been diagnosed with any diseases that affect joints is present in either knee including knee osteoarthritis inflammatory arthritis
* Pregnant or plans to become pregnant over next 4 months
* Body mass index (BMI) ≥ 36 kg/m2
* Unable to speak English
* Cochlear implant
* Metal in body (metal fragments, shrapnel, permanent make-up, body piercings that cannot be removed)
* Claustrophobia
* History of seizures
* Pacemaker
16 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
University of Georgia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Caroline Lisee, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Georgia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Georgia
Athens, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PROJECT00008276
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.